Ebola

The results of a recent Phase IB study show that the novel Ebola vaccine, V920, was well-tolerated and “stimulated a rapid onset of binding and neutralizing antibodies,” which persisted for up to 1 year.

New drugs for HIV, the growing rate of antibiotic resistance, a new hepatitis C treatment option, and updates on the Ebola outbreak and Lyme disease diagnostics, make up the Top 5 articles for this week.

A viral protein may be behind the rapid spread of the Ebola virus.

ASM member Kate Rubins, PhD, first individual to sequence DNA in space, shed light on her experience as a NASA astronaut in a keynote conversation at the ASM Microbe 2017 meeting in New Orleans, Louisiana.

As the Ebola outbreak in the Democratic Republic of Congo holds steady at 2 confirmed and 3 probable cases, the Ministry of Health has approved the administration of an experimental vaccine against the virus.

In case you missed them, here are our top 5 articles for the week of May 21, 2017.

While the 2016 Ebola outbreak in the Democratic Republic of Congo continues to unfold, researchers have identified the first natural human antibodies against all three major disease-causing ebolaviruses.

The World Health Organization (WHO) has released more information on the cases of Ebola virus infection recently discovered in the Democratic Republic of Congo.

The World Health Organization has just confirmed a case of Ebola virus in the Democratic Republic of Congo.

We are adding 2 more reasons to the 7 reasons we are more at risk than ever for a global pandemic.

In a case study published in Science Translational Medicine, researchers describe what they believe is the host response to the blood-borne disease that has plagued several countries in Africa and caused world-wide panic.

Researchers from the University of Oxford and Janssen Pharmaceuticals believe they have demonstrated an Ebola vaccine approach that fosters immunity for up to 1 year.

The first international Open Science Prize has been awarded to Fred Hutchinson Cancer Research Center and University of Basel researchers for a software tool that is capable of tracking viral disease outbreaks.

Did you read this week’s top infectious disease news coverage from Contagion®?

Members of Doctors Without Borders/Medecins Sans Frontieres discussed the aftermath of the 2014-2015 epidemic in a recent webcast.

The Centers for Disease Control and Prevention recently published a study detailing a case of Ebola virus RNA persistence in the semen of a male Ebola survivor with HIV.

A new study reports that a substantial proportion of secondary cases in the 2014 to 2015 Ebola epidemic descended from a small number of superspreaders.

Researchers have found potential evidence that suggests Ebola may be able to replicate in the lungs of recovering patients.

A new coalition created by the Bill & Melinda Gates Foundation and other global partners will launch at this year’s World Economic Forum, with the goal of supporting the fast-tracked development of new vaccines.

Researchers from Erasmus disease the key factors needed for successful human-to-human contact-transmission of zoonotic pathogens.

Researchers have found that an experimental vaccine designed to fight the Ebola virus has proven to be highly protective.

A defense mechanism by which plants and animals fight off RNA viruses was recently observed in human cells for the first time, offering researchers a look at new ways to treat viral diseases.

Thomas Frieden, MD, MPH, director of the CDC, and Susan Desmond-Hellmann, MD, chief executive of the Bill and Melinda Gates Foundation discuss how governments and business organizations should prepare for pandemics, especially a potential influenza pandemic.

A new potential case of the Ebola virus has been reported in Canada.

Studies find that a mutated gene that encodes the Ebola virus glycoprotein increased its ability to infect human and primate cells in the 2013-2106 West African epidemic.

The huge economic toll of widespread disease is rarely accounted for when officials set budgets—with the result that countries frequently find their finances in shambles during and after a pandemic.

The transdermal vaccine route offers an opportunity to improve vaccine administration.

In a collaborative effort, researchers have discovered what they refer to as a “Trojan Horse” strategy that uses two developed bispecific antibodies that have proved active against all five strains of the ebolavirus.

A new study has shown that infected wild house mice will disengage from their social groups, resulting in a decreased potential for disease transmission; these findings can be applied to improve models used to predict transmission of infectious diseases spread by social contact, such as Ebola and influenza.

A new report from Liberia’s Men’s Health Screening Program provides insight into the persistence of the Ebola virus in the semen of survivors.